Histamin-Kontrollösung 1% Pricktestlösung Wirkstoff: Histamindihydrochlorid
Sponsors
Allergy Therapeutics (UK) Limited, Inmunotek S.L.
Conditions
Seasonal allergic rhinitis/rhinoconjunctivitis induced by grass pollen exposurebirch pollen-induced allergic rhinitis
birch pollen-induced allergic rhinoconjunctivitis
Phase 3
A long-term, double-blind, randomised, placebo-controlled clinical trial to investigate the efficacy and safety of PQ Grass 27600 SU in children and adolescents with seasonal allergic rhinitis/rhinoconjunctivitis induced by grass pollen exposure
RecruitingCTIS2023-508520-36-00
Start: 2024-09-06Target: 358Updated: 2025-12-09
A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered subcutaneously to adolescents and adults with birch pollen-induced allergic rhinitis or rhinoconjunctivitis.
CompletedCTIS2024-515717-17-00
Start: 2024-10-28End: 2025-06-27Target: 360Updated: 2025-08-07